Concepts (140)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Biological Specimen Banks | 5 | 2024 | 51 | 1.560 |
Why?
|
| Genetic Variation | 5 | 2024 | 1476 | 1.130 |
Why?
|
| Neurodevelopmental Disorders | 2 | 2023 | 469 | 1.100 |
Why?
|
| Genetic Predisposition to Disease | 11 | 2025 | 3083 | 0.980 |
Why?
|
| Genomics | 6 | 2024 | 1472 | 0.910 |
Why?
|
| Genome, Human | 5 | 2022 | 1261 | 0.890 |
Why?
|
| Blood Proteins | 1 | 2023 | 116 | 0.860 |
Why?
|
| Biological Evolution | 2 | 2022 | 221 | 0.820 |
Why?
|
| Epilepsy | 2 | 2023 | 859 | 0.790 |
Why?
|
| Transcriptome | 3 | 2024 | 909 | 0.760 |
Why?
|
| Selection, Genetic | 3 | 2022 | 150 | 0.750 |
Why?
|
| Proteomics | 2 | 2024 | 477 | 0.740 |
Why?
|
| Genetic Association Studies | 2 | 2023 | 758 | 0.710 |
Why?
|
| Neurons | 5 | 2024 | 1933 | 0.680 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2022 | 423 | 0.680 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2021 | 112 | 0.670 |
Why?
|
| Neural Stem Cells | 1 | 2020 | 126 | 0.660 |
Why?
|
| Mutation, Missense | 3 | 2025 | 846 | 0.620 |
Why?
|
| Schizophrenia | 2 | 2021 | 297 | 0.580 |
Why?
|
| Genetic Testing | 1 | 2024 | 995 | 0.570 |
Why?
|
| Cell Cycle Proteins | 1 | 2021 | 658 | 0.550 |
Why?
|
| Complement C4 | 1 | 2016 | 5 | 0.530 |
Why?
|
| Genome-Wide Association Study | 7 | 2024 | 1634 | 0.510 |
Why?
|
| United Kingdom | 6 | 2024 | 192 | 0.480 |
Why?
|
| Gene Expression Regulation | 1 | 2020 | 2541 | 0.390 |
Why?
|
| Germ-Line Mutation | 2 | 2025 | 314 | 0.390 |
Why?
|
| Exome | 3 | 2023 | 1042 | 0.370 |
Why?
|
| Machine Learning | 2 | 2024 | 213 | 0.370 |
Why?
|
| Single-Cell Analysis | 2 | 2024 | 267 | 0.340 |
Why?
|
| Mutation | 6 | 2023 | 5794 | 0.310 |
Why?
|
| Biomarkers | 3 | 2024 | 2947 | 0.270 |
Why?
|
| Software | 2 | 2022 | 673 | 0.260 |
Why?
|
| Humans | 25 | 2025 | 122853 | 0.250 |
Why?
|
| Anticonvulsants | 2 | 2020 | 372 | 0.250 |
Why?
|
| Whole Genome Sequencing | 2 | 2024 | 285 | 0.250 |
Why?
|
| Checkpoint Kinase 2 | 1 | 2025 | 35 | 0.250 |
Why?
|
| Case-Control Studies | 5 | 2025 | 3245 | 0.250 |
Why?
|
| BRCA2 Protein | 1 | 2025 | 44 | 0.240 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2024 | 379 | 0.240 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2025 | 92 | 0.240 |
Why?
|
| Rhombencephalon | 1 | 2024 | 45 | 0.230 |
Why?
|
| PubMed | 1 | 2023 | 21 | 0.220 |
Why?
|
| Telomere | 1 | 2024 | 205 | 0.210 |
Why?
|
| Plasma | 1 | 2023 | 96 | 0.210 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2022 | 48 | 0.210 |
Why?
|
| Databases, Genetic | 2 | 2024 | 469 | 0.210 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2022 | 8 | 0.200 |
Why?
|
| Focal Adhesion Kinase 2 | 1 | 2022 | 7 | 0.200 |
Why?
|
| Cell Lineage | 1 | 2024 | 348 | 0.200 |
Why?
|
| Haploinsufficiency | 1 | 2023 | 248 | 0.200 |
Why?
|
| Databases, Factual | 2 | 2023 | 1163 | 0.190 |
Why?
|
| Hematopoiesis | 1 | 2023 | 220 | 0.190 |
Why?
|
| Phenotype | 5 | 2024 | 4220 | 0.190 |
Why?
|
| Epilepsy, Generalized | 1 | 2022 | 64 | 0.190 |
Why?
|
| Homozygote | 1 | 2023 | 535 | 0.190 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2024 | 2583 | 0.190 |
Why?
|
| Epirizole | 1 | 2020 | 2 | 0.190 |
Why?
|
| Trimipramine | 1 | 2020 | 2 | 0.190 |
Why?
|
| Perphenazine | 1 | 2020 | 6 | 0.190 |
Why?
|
| Trazodone | 1 | 2020 | 7 | 0.180 |
Why?
|
| Carbamazepine | 1 | 2020 | 49 | 0.180 |
Why?
|
| Heterozygote | 1 | 2023 | 682 | 0.180 |
Why?
|
| Naloxone | 1 | 2020 | 46 | 0.180 |
Why?
|
| Primary Cell Culture | 1 | 2020 | 102 | 0.180 |
Why?
|
| Codon | 1 | 2020 | 97 | 0.180 |
Why?
|
| MCF-7 Cells | 1 | 2020 | 222 | 0.170 |
Why?
|
| Risperidone | 1 | 2020 | 56 | 0.170 |
Why?
|
| Computational Biology | 3 | 2024 | 794 | 0.170 |
Why?
|
| Disease | 1 | 2021 | 129 | 0.170 |
Why?
|
| Narcotic Antagonists | 1 | 2020 | 104 | 0.170 |
Why?
|
| RNA Stability | 1 | 2020 | 85 | 0.170 |
Why?
|
| Cerebellum | 1 | 2023 | 414 | 0.170 |
Why?
|
| Hematologic Neoplasms | 1 | 2022 | 272 | 0.160 |
Why?
|
| Drug Discovery | 1 | 2020 | 171 | 0.160 |
Why?
|
| RNA Splicing | 1 | 2020 | 223 | 0.160 |
Why?
|
| Genotype | 2 | 2023 | 2536 | 0.160 |
Why?
|
| Animals | 8 | 2024 | 33923 | 0.160 |
Why?
|
| Alleles | 1 | 2023 | 1599 | 0.160 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2020 | 191 | 0.160 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2020 | 303 | 0.150 |
Why?
|
| Amino Acid Sequence | 1 | 2022 | 2702 | 0.150 |
Why?
|
| Antidepressive Agents | 1 | 2020 | 286 | 0.150 |
Why?
|
| Computer Simulation | 1 | 2020 | 616 | 0.150 |
Why?
|
| Antipsychotic Agents | 1 | 2020 | 367 | 0.140 |
Why?
|
| Evolution, Molecular | 1 | 2020 | 670 | 0.140 |
Why?
|
| Mice | 6 | 2024 | 17647 | 0.130 |
Why?
|
| Prostatic Neoplasms | 1 | 2025 | 1518 | 0.130 |
Why?
|
| Action Potentials | 1 | 2018 | 499 | 0.130 |
Why?
|
| Electrodes, Implanted | 1 | 2015 | 162 | 0.120 |
Why?
|
| Gene Expression Profiling | 1 | 2020 | 1680 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2022 | 1216 | 0.100 |
Why?
|
| Aged | 4 | 2024 | 18917 | 0.100 |
Why?
|
| Algorithms | 3 | 2024 | 1581 | 0.100 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2015 | 446 | 0.090 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 865 | 0.080 |
Why?
|
| Genetics, Population | 2 | 2022 | 185 | 0.080 |
Why?
|
| Male | 6 | 2025 | 59866 | 0.070 |
Why?
|
| Cell Differentiation | 2 | 2024 | 1936 | 0.070 |
Why?
|
| Female | 5 | 2024 | 65278 | 0.060 |
Why?
|
| Telomere Homeostasis | 1 | 2024 | 44 | 0.060 |
Why?
|
| Telomerase | 1 | 2025 | 167 | 0.060 |
Why?
|
| Multifactorial Inheritance | 1 | 2024 | 138 | 0.060 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2023 | 25 | 0.060 |
Why?
|
| DNA Helicases | 1 | 2024 | 226 | 0.050 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2022 | 32 | 0.050 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2022 | 23 | 0.050 |
Why?
|
| Neurogenesis | 1 | 2024 | 196 | 0.050 |
Why?
|
| Receptors, GABA-A | 1 | 2022 | 59 | 0.050 |
Why?
|
| Cell Division | 1 | 2023 | 793 | 0.050 |
Why?
|
| src-Family Kinases | 1 | 2022 | 91 | 0.050 |
Why?
|
| Drug Delivery Systems | 1 | 2022 | 181 | 0.050 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2021 | 83 | 0.050 |
Why?
|
| DNA, Intergenic | 1 | 2021 | 16 | 0.050 |
Why?
|
| Germ Cells | 1 | 2022 | 193 | 0.050 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2022 | 147 | 0.050 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2022 | 167 | 0.050 |
Why?
|
| Cell Movement | 1 | 2024 | 838 | 0.050 |
Why?
|
| Loss of Function Mutation | 1 | 2021 | 143 | 0.050 |
Why?
|
| Cell Cycle | 1 | 2023 | 619 | 0.040 |
Why?
|
| RNA | 1 | 2023 | 577 | 0.040 |
Why?
|
| Lipids | 1 | 2023 | 512 | 0.040 |
Why?
|
| Risk | 1 | 2021 | 744 | 0.040 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2024 | 1007 | 0.040 |
Why?
|
| Middle Aged | 3 | 2024 | 25798 | 0.040 |
Why?
|
| Microelectrodes | 1 | 2018 | 39 | 0.040 |
Why?
|
| Seizures | 1 | 2023 | 875 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2022 | 1617 | 0.040 |
Why?
|
| Electrophysiology | 1 | 2018 | 269 | 0.040 |
Why?
|
| Open Reading Frames | 1 | 2017 | 212 | 0.030 |
Why?
|
| Developmental Disabilities | 1 | 2021 | 695 | 0.030 |
Why?
|
| Autism Spectrum Disorder | 1 | 2021 | 374 | 0.030 |
Why?
|
| Proteins | 1 | 2021 | 1045 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2021 | 1760 | 0.030 |
Why?
|
| Models, Genetic | 1 | 2017 | 748 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 2827 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2018 | 3075 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2022 | 5996 | 0.020 |
Why?
|
| Obesity | 1 | 2022 | 2089 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2018 | 3782 | 0.020 |
Why?
|
| Adult | 1 | 2021 | 28926 | 0.010 |
Why?
|